Axis44
ActiveAxis44 has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.24M and a net result of €1.42M. Equity is growing by ~47.3% per year across the filed fiscal years. Its solvency ranks better than 85% of 521 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Score 2025
92
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Track record94
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €200k at 30 days acceptable
Liquidity ample (current ratio 11.82 against 10.68 in 2024; short-term debt: 8.4% and cash: 67.7% of total assets), and 8.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
91.6%
Return on assets
58.2%
Age of the figures
9 mo
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
8 d early
2024
14 d early
2023
2 d late
2022
15 d early
2021
30 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€2.24M▲ 174%
2024 · €818k
2021: €63k
2022: €442k
2023: €781k
2024: €818k
2021 → 2025
Total assets
€2.45M▲ 172%
2024 · €900k
2021: €131k
2022: €601k
2023: €962k
2024: €900k
2021 → 2025
Net result
€1.42M▲ 423%
2024 · €272k
2021: €58k
2022: €380k
2023: €339k
2024: €272k
2021 → 2025
Working capital
€2.22M▲ 180%
2024 · €794k
2021: €44k
2022: €429k
2023: €771k
2024: €794k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€63k-€442k▲ 607%€781k▲ 76.7%€818k▲ 4.7%€2.24M▲ 174%
Operating result€94k-€494k▲ 423%€432k▼ 12.4%€432k▼ 0.2%€2.08M▲ 382%
Net result€58k-€380k▲ 560%€339k▼ 10.7%€272k▼ 19.8%€1.42M▲ 423%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 382% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.45M
Fixed assets
€19k▼ 21.4%
Current assets
€2.43M▲ 177%
Equity and liabilities €2.45M
Equity
€2.24M▲ 174%
Debt
€205k▲ 150%
The debt ratio falls from 9.1% to 8.4%. Equity and debt are higher.
Key figures and ratios
EBITDA
€2.09M▲
2024 · €453k
Cash flow
€1.44M▲
2024 · €294k
Solvency
91.6%▲
2024 · 90.9%
Current ratio
11.82▲
2024 · 10.68
Quick ratio
11.82▲
2024 · 10.68
Debt / equity
0.09▼
2024 · 0.10
ROE
63.5%▲
2024 · 33.3%
ROA
58.2%▲
2024 · 30.2%
Interest coverage
1792.26▲
2024 · 8.09
Debt
€205k▲
2024 · €82k
Debt ≤ 1 year
€205k▲
2024 · €82k
Income taxes
€679k▲
2024 · €105k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€900k€2.45M▲
Fixed assets21/28€24k€19k▼
Tangible fixed assets22/27€24k€19k▼
Furniture and vehicles24€24k€19k▼
Current assets29/58€876k€2.43M▲
Amounts receivable within one year40/41€257k€278k▲
Trade receivables40€240k€266k▲
Other amounts receivable41€16k€11k▼
Current investments50/53€490k€490k=
Cash at bank and in hand54/58€126k€1.66M▲
Deferred charges and accrued income490/1€4k€5k▲
Equity and liabilities
Total equity and liabilities10/49€900k€2.45M▲
Equity10/15€818k€2.24M▲
Contributions10/11€5k€5k=
Reserves13-€1.42M
Distributable reserves133-€1.42M
Profit (loss) carried forward14€813k€813k=
Amounts payable17/49€82k€205k▲
Amounts payable after more than one year17€0-
Financial debts170/4€0-
Amounts payable within one year42/48€82k€205k▲
Current portion of amounts payable after more than one year42€8k€0▼
Trade debts44€5k€3k▼
Suppliers440/4€5k€3k▼
Taxes, remuneration and social security45€50k€187k▲
Taxes450/3€50k€183k▲
Remuneration and social security454/9€0€4k▲
Other amounts payable47/48€20k€16k▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€22k€12k▼
Other operating charges640/8€1k€1k▲
Gross operating margin9900€454k€2.09M▲
Operating profit (loss)9901€432k€2.08M▲
Financial income75/76B€2k€26k▲
Recurring financial income75€2k€26k▲
Financial charges65/66B€56k€1k▼
Recurring financial charges65€56k€1k▼
Profit (loss) for the period before taxes9903€377k€2.10M▲
Income taxes67/77€105k€679k▲
Profit (loss) for the period9904€272k€1.42M▲
Profit (loss) for the period to be appropriated9905€272k€1.42M▲
Appropriation of the result
Profit (loss) to be appropriated9906€1.05M€2.24M▲
Profit (loss) brought forward from the previous period14P€776k€813k▲
Transfer to equity691/2-€1.42M
To other reserves6921-€1.42M
Profit to be distributed694/7€235k€0▼
Return on contributions (dividend)694€235k€0▼
The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
23-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2021net €1.42M ▲423%
Operating result €2.08M, net result €1.42M, both a record.
31-12
Financial
Equity above €2MEq €2.24M ▲174%
5 profitable years in a row build equity to €2.24M.
17-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
02-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 2 days late
2023
31-12
Financial
Equity above €500kEq €781k ▲76.7%
3 profitable years in a row build equity to €781k.
16-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Equity above €200kEq €442k ▲607%
2 profitable years in a row build equity to €442k.
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Jodoigne · 1 establishment unit since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue d'Orbais(Jauch.) 191370 JodoigneGround area
2,137 m²
Building footprint
152 m²
Volume, LiDAR
1,049 m³
Parcel 25047B0180/00A000, Wallonia · tallest building 9.3 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
AXIS44
since 20212.319.891.194
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25047B0180/00A000 | Wallonia | 2,137 m² | 1 · 152 m² | 9.3 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
6994003GLDHHVSQRWC03
Similar companies · same sector, comparable size
Celyad Oncology
BE 0891.118.115
Mont-Saint-Guibert · Eq €2.24M
Dokter Geert De Bruecker - Neuropsychiatrie
BE 0471.670.022
Lede · Eq €2.26M
CENTRE D'ETUDE ET DE TRAITEMENT EN OPHTALMOLOGIE
BE 0826.214.623
Brussel · Eq €2.32M
POULPHARM
BE 0888.282.250
Izegem · Eq €2.17M
Inhatarget Therapeutics
BE 0732.994.752
Charleroi · Eq €2.16M
Of 761 companies in sector 72101 we hold annual accounts for 481. 253 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded04-05-2021
Fiscal year end31-12
Activities, NACEBEL
72101Research and development on biotechnology
72109Other research and development on natural sciences
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.